TD Asset Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-63,827
| Closed | -$629K | – | 1515 |
|
|
2021
Q1 | $629K | Buy |
63,827
+12,826
| +25% | +$126K | ﹤0.01% | 1360 |
|
|
2020
Q4 | $553K | Buy |
51,001
+7,500
| +17% | +$81.3K | ﹤0.01% | 1315 |
|
|
2020
Q3 | $448K | Sell |
43,501
-30,000
| -41% | -$309K | ﹤0.01% | 1266 |
|
|
2020
Q2 | $1.54M | Buy |
73,501
+963
| +1% | +$20.1K | ﹤0.01% | 945 |
|
|
2020
Q1 | $709K | Buy |
72,538
+15,988
| +28% | +$156K | ﹤0.01% | 1089 |
|
|
2019
Q4 | $651K | Sell |
56,550
-3,700
| -6% | -$42.6K | ﹤0.01% | 1192 |
|
|
2019
Q3 | $328K | Buy |
60,250
+45,650
| +313% | +$249K | ﹤0.01% | 1239 |
|
|
2019
Q2 | $174K | Buy |
+14,600
| New | +$174K | ﹤0.01% | 1306 |
|
|
2015
Q2 | – | Sell |
-24,338
| Closed | -$986K | – | 1397 |
|
|
2015
Q1 | $986K | Buy |
24,338
+16,838
| +225% | +$682K | ﹤0.01% | 945 |
|
|
2014
Q4 | $405K | Hold |
7,500
| – | – | ﹤0.01% | 1151 |
|
|
2014
Q3 | $256K | Buy |
+7,500
| New | +$256K | ﹤0.01% | 1191 |
|